Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 584

1.

Monitoring fluorescence response of amphiphilic flapping molecules in compressed monolayers at the air-water interface.

Nakanishi W, Saito S, Sakamoto N, Kashiwagi A, Yamaguchi S, Sakai H, Ariga K.

Chem Asian J. 2019 Jul 9. doi: 10.1002/asia.201900769. [Epub ahead of print]

PMID:
31290274
2.
3.

Preserving β-cell function is the major determinant of diabetes remission following laparoscopic sleeve gastrectomy in Japanese obese diabetic patients.

Ugi S, Morino K, Yamaguchi T, Yamamoto H, Kaida S, Miyazawa I, Sato D, Sekine O, Fujita Y, Kashiwagi A, Tani M, Maegawa H.

Endocr J. 2019 Jun 1. doi: 10.1507/endocrj.EJ19-0054. [Epub ahead of print]

4.

Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014.

Kume S, Araki SI, Ugi S, Morino K, Koya D, Nishio Y, Haneda M, Kashiwagi A, Maegawa H.

J Diabetes Investig. 2019 Jul;10(4):1032-1040. doi: 10.1111/jdi.12977. Epub 2019 Jan 1.

5.

Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study.

Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators.

Diabetes Obes Metab. 2018 Nov 4. doi: 10.1111/dom.13575. [Epub ahead of print]

6.

Corrigendum to "Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population." [Atherosclerosis 246 (March 2016) 141-147].

Ueshima H, Kadowaki T, Hisamatsu T, Fujiyoshi A, Miura K, Ohkubo T, Sekikawa A, Kadota A, Kadowaki S, Nakamura Y, Miyagawa N, Okamura T, Kita Y, Takashima N, Kashiwagi A, Maegawa H, Horie M, Yamamoto T, Kimura T, Kita T; ACCESS and SESSA Research Groups.

Atherosclerosis. 2018 Nov;278:336. doi: 10.1016/j.atherosclerosis.2018.07.039. Epub 2018 Aug 27. No abstract available.

PMID:
30166205
7.

A Lytic Bacteriophage for Controlling Pseudomonas lactis in Raw Cow's Milk.

Tanaka C, Yamada K, Takeuchi H, Inokuchi Y, Kashiwagi A, Toba T.

Appl Environ Microbiol. 2018 Aug 31;84(18). pii: e00111-18. doi: 10.1128/AEM.00111-18. Print 2018 Sep 15.

8.

Influence of adaptive mutations, from thermal adaptation experiments, on the infection cycle of RNA bacteriophage Qβ.

Kashiwagi A, Kadoya T, Kumasaka N, Kumagai T, Tsushima FS, Yomo T.

Arch Virol. 2018 Oct;163(10):2655-2662. doi: 10.1007/s00705-018-3895-6. Epub 2018 Jun 4.

PMID:
29869034
9.

Improved cardiometabolic risk factors in Japanese patients with type 2 diabetes treated with ipragliflozin: a pooled analysis of six randomized, placebo-controlled trials.

Kashiwagi A, Sakatani T, Nakamura I, Akiyama N, Kazuta K, Ueyama E, Takahashi H, Kosakai Y.

Endocr J. 2018 Jul 28;65(7):693-705. doi: 10.1507/endocrj.EJ17-0491. Epub 2018 May 29.

10.

Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study.

Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators.

Diabetes Care. 2018 Jun;41(6):1275-1284. doi: 10.2337/dc17-2224. Epub 2018 Apr 6.

PMID:
29626074
11.

Correction: The constant threat from a non-native predator increases tail muscle and fast-start swimming performance in Xenopus tadpoles.

Mori T, Yanagisawa Y, Kitani Y, Yamamoto G, Goto-Inoue N, Kimura T, Kashiwagi K, Kashiwagi A.

Biol Open. 2018 Jan 16;7(1). pii: bio031443. doi: 10.1242/bio.031443. No abstract available.

12.

Utilizing mass spectrometry imaging to map the thyroid hormones triiodothyronine and thyroxine in Xenopus tropicalis tadpoles.

Goto-Inoue N, Sato T, Morisasa M, Kashiwagi A, Kashiwagi K, Sugiura Y, Sugiyama E, Suematsu M, Mori T.

Anal Bioanal Chem. 2018 Feb;410(4):1333-1340. doi: 10.1007/s00216-017-0775-y. Epub 2017 Dec 15.

PMID:
29247380
13.

Definitive diagnosis of mandibular hypoplasia, deafness, progeroid features and lipodystrophy (MDPL) syndrome caused by a recurrent de novo mutation in the POLD1 gene.

Sasaki H, Yanagi K, Ugi S, Kobayashi K, Ohkubo K, Tajiri Y, Maegawa H, Kashiwagi A, Kaname T.

Endocr J. 2018 Feb 26;65(2):227-238. doi: 10.1507/endocrj.EJ17-0287. Epub 2017 Dec 2.

14.

The constant threat from a non-native predator increases tail muscle and fast-start swimming performance in Xenopus tadpoles.

Mori T, Yanagisawa Y, Kitani Y, Yamamoto G, Goto-Inoue N, Kimura T, Kashiwagi K, Kashiwagi A.

Biol Open. 2017 Nov 15;6(11):1726-1733. doi: 10.1242/bio.029926. Erratum in: Biol Open. 2018 Jan 16;7(1):.

15.

Impact of obesity on annual medical expenditures and diabetes care in Japanese patients with type 2 diabetes mellitus.

Kusunoki-Tsuji C, Araki SI, Kume S, Chin-Kanasaki M, Osawa N, Morino K, Sekine O, Ugi S, Kashiwagi A, Maegawa H.

J Diabetes Investig. 2018 Jul;9(4):776-781. doi: 10.1111/jdi.12766. Epub 2017 Nov 22. Erratum in: J Diabetes Investig. 2019 Mar;10(2):554.

16.

Developmental changes in drug-metabolizing enzyme expression during metamorphosis of Xenopus tropicalis.

Mori J, Sanoh S, Kashiwagi K, Hanada H, Shigeta M, Suzuki KT, Yamamoto T, Kotake Y, Sugihara K, Kitamura S, Kashiwagi A, Ohta S.

J Toxicol Sci. 2017;42(5):605-613. doi: 10.2131/jts.42.605.

17.

Impact of Surgeon and Hospital Volume on the Safety of Robot-Assisted Radical Prostatectomy: A Multi-Institutional Study Based on a National Database.

Hirasawa Y, Yoshioka K, Nasu Y, Yamamoto M, Hinotsu S, Takenaka A, Fujisawa M, Shiroki R, Tozawa K, Fukasawa S, Kashiwagi A, Tatsugami K, Tachibana M, Terachi T, Gotoh M; Japanese Society of Endourology.

Urol Int. 2017;98(3):334-342. doi: 10.1159/000460304. Epub 2017 Mar 3.

PMID:
28253500
18.
19.

Reality of nerve sparing and surgical margins in surgeons' early experience with robot-assisted radical prostatectomy in Japan.

Tatsugami K, Yoshioka K, Shiroki R, Eto M, Yoshino Y, Tozawa K, Fukasawa S, Fujisawa M, Takenaka A, Nasu Y, Kashiwagi A, Gotoh M, Terachi T; Japanese Society of Endourology.

Int J Urol. 2017 Mar;24(3):191-196. doi: 10.1111/iju.13281. Epub 2017 Jan 25.

20.

Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial.

Uzu T, Araki SI, Kashiwagi A, Haneda M, Koya D, Yokoyama H, Kida Y, Ikebuchi M, Nakamura T, Nishimura M, Takahara N, Obata T, Omichi N, Sakamoto K, Shingu R, Taki H, Nagai Y, Tokuda H, Kitada M, Misawa M, Nishiyama A, Kobori H, Maegawa H; Shiga Committee for Preventing Diabetic Nephropathy.

PLoS One. 2016 Dec 29;11(12):e0164936. doi: 10.1371/journal.pone.0164936. eCollection 2016.

21.

Hypothalamic AMP-Activated Protein Kinase Regulates Biphasic Insulin Secretion from Pancreatic β Cells during Fasting and in Type 2 Diabetes.

Kume S, Kondo M, Maeda S, Nishio Y, Yanagimachi T, Fujita Y, Haneda M, Kondo K, Sekine A, Araki SI, Araki H, Chin-Kanasaki M, Ugi S, Koya D, Kitahara S, Maeda K, Kashiwagi A, Uzu T, Maegawa H.

EBioMedicine. 2016 Nov;13:168-180. doi: 10.1016/j.ebiom.2016.10.038. Epub 2016 Oct 28.

22.

Effects of ipragliflozin, a selective sodium-glucose co-transporter 2 inhibitor, on blood pressure in Japanese patients with type 2 diabetes mellitus: a pooled analysis of six randomized, placebo-controlled clinical trials.

Kashiwagi A, Yoshida S, Kawamuki K, Nakamura I, Kazuta K, Ueyama E, Takahashi H, Akiyama N, Kondo Y, Ogihara T.

Diabetol Int. 2016 Sep 9;8(1):76-86. doi: 10.1007/s13340-016-0283-x. eCollection 2017 Mar.

23.

Evaluation of a Novel Glucose Area Under the Curve (AUC) Monitoring System: Comparison with the AUC by Continuous Glucose Monitoring.

Ugi S, Maegawa H, Morino K, Nishio Y, Sato T, Okada S, Kikkawa Y, Watanabe T, Nakajima H, Kashiwagi A.

Diabetes Metab J. 2016 Aug;40(4):326-33. doi: 10.4093/dmj.2016.40.4.326. Epub 2016 Jul 26.

24.

Metabolomic approach for identifying and visualizing molecular tissue markers in tadpoles of Xenopus tropicalis by mass spectrometry imaging.

Goto-Inoue N, Kashiwagi A, Kashiwagi K, Mori T.

Biol Open. 2016 Sep 15;5(9):1252-9. doi: 10.1242/bio.019646.

25.

Relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetic patients (JDDM38).

Kanatsuka A, Sato Y, Kawai K, Hirao K, Kobayashi M, Kashiwagi A; Japan Diabetes Clinical Data Management Study Group (JDDM), Abe N, Arai K, Fujiya H, Fukumoto Y, Dake F, Iizumi T, Ito M, Iwasaki K, Kanamori A, Kato S, Kato M, Kawara A, Kimura K, Chikamori K, Iemitsu K, Kou S, Kudo M, Kurihara Y, Lee G, Tsuruoka A, Manda N, Matoba K, Hayashi H, Minami M, Kuribayashi N, Miyazawa K, Chiba Y, Osonoi T, Nakamura S, Sasaki H, Komori K, Oishi M, Okada A, Okuguchi F, Yanagisawa M, Sugimoto H, Sugiyama H, Takai M, Takaki M, Takamura H, Takeda H, Takeda H, Tanaka K, Miwa T, Tomonaga O, Taguchi M, Yamazaki K, Wada T, Yagi N, Yamaoka K, Yuhara A.

J Diabetes Investig. 2016 May;7(3):386-95. doi: 10.1111/jdi.12430. Epub 2015 Nov 12.

26.

Rapid and efficient analysis of gene function using CRISPR-Cas9 in Xenopus tropicalis founders.

Shigeta M, Sakane Y, Iida M, Suzuki M, Kashiwagi K, Kashiwagi A, Fujii S, Yamamoto T, Suzuki KT.

Genes Cells. 2016 Jul;21(7):755-71. doi: 10.1111/gtc.12379. Epub 2016 May 24.

27.

Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes stratified by body mass index: A subgroup analysis of five randomized clinical trials.

Kashiwagi A, Yoshida S, Nakamura I, Kazuta K, Ueyama E, Takahashi H, Satomi H, Kosakai Y, Kawamuki K.

J Diabetes Investig. 2016 Jul;7(4):544-54. doi: 10.1111/jdi.12471. Epub 2016 Mar 1.

28.

Replication Study in a Japanese Population of Six Susceptibility Loci for Type 2 Diabetes Originally Identified by a Transethnic Meta-Analysis of Genome-Wide Association Studies.

Matsuba R, Imamura M, Tanaka Y, Iwata M, Hirose H, Kaku K, Maegawa H, Watada H, Tobe K, Kashiwagi A, Kawamori R, Maeda S.

PLoS One. 2016 Apr 26;11(4):e0154093. doi: 10.1371/journal.pone.0154093. eCollection 2016.

29.

Comparison of clinical characteristics in patients with type 2 diabetes among whom different antihyperglycemic agents were prescribed as monotherapy or combination therapy by diabetes specialists.

Fujihara K, Hanyu O, Heianza Y, Suzuki A, Yamada T, Yokoyama H, Tanaka S, Yagyu H, Shimano H, Kashiwagi A, Yamazaki K, Kawai K, Sone H.

J Diabetes Investig. 2016 Mar;7(2):260-9. doi: 10.1111/jdi.12387. Epub 2015 Jul 26.

30.

Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: Results from a randomized, 52-week, open-label study.

Yasuda H, Hotta N, Kasuga M, Kashiwagi A, Kawamori R, Yamada T, Baba Y, Alev L, Nakajo K.

J Diabetes Investig. 2016 Jan;7(1):100-8. doi: 10.1111/jdi.12361. Epub 2015 May 18.

31.

Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.

Ueshima H, Kadowaki T, Hisamatsu T, Fujiyoshi A, Miura K, Ohkubo T, Sekikawa A, Kadota A, Kadowaki S, Nakamura Y, Miyagawa N, Okamura T, Kita Y, Takashima N, Kashiwagi A, Maegawa H, Horie M, Yamamoto T, Kimura T, Kita T; ACCESS and SESSA Research Groups.

Atherosclerosis. 2016 Mar;246:141-7. doi: 10.1016/j.atherosclerosis.2015.12.027. Epub 2015 Dec 23. Erratum in: Atherosclerosis. 2018 Nov;278:336.

PMID:
26775119
32.

Duality of n-3 Polyunsaturated Fatty Acids on Mcp-1 Expression in Vascular Smooth Muscle: A Potential Role of 4-Hydroxy Hexenal.

Nagayama K, Morino K, Sekine O, Nakagawa F, Ishikado A, Iwasaki H, Okada T, Tawa M, Sato D, Imamura T, Nishio Y, Ugi S, Kashiwagi A, Okamura T, Maegawa H.

Nutrients. 2015 Sep 21;7(9):8112-26. doi: 10.3390/nu7095381.

33.

Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36).

Yokoyama H, Araki S, Kawai K, Hirao K, Oishi M, Sugimoto K, Sone H, Maegawa H, Kashiwagi A; Japan Diabetes Clinical Data Management Study Group.

Diabetes Res Clin Pract. 2015 Sep;109(3):485-92. doi: 10.1016/j.diabres.2015.06.005. Epub 2015 Jul 16.

PMID:
26261056
34.

Inbreeding Ratio and Genetic Relationships among Strains of the Western Clawed Frog, Xenopus tropicalis.

Igawa T, Watanabe A, Suzuki A, Kashiwagi A, Kashiwagi K, Noble A, Guille M, Simpson DE, Horb ME, Fujii T, Sumida M.

PLoS One. 2015 Jul 29;10(7):e0133963. doi: 10.1371/journal.pone.0133963. eCollection 2015.

35.

Right unilateral spatial neglect in aphasic patients.

Ihori N, Kashiwagi A, Kashiwagi T.

Brain Lang. 2015 Aug;147:21-9. doi: 10.1016/j.bandl.2015.05.001. Epub 2015 May 23.

PMID:
26011744
36.

Glucose area under the curve during oral glucose tolerance test as an index of glucose intolerance.

Sakaguchi K, Takeda K, Maeda M, Ogawa W, Sato T, Okada S, Ohnishi Y, Nakajima H, Kashiwagi A.

Diabetol Int. 2015 May 14;7(1):53-58. doi: 10.1007/s13340-015-0212-4. eCollection 2016 Mar.

37.

Replication Study in a Japanese Population to Evaluate the Association between 10 SNP Loci, Identified in European Genome-Wide Association Studies, and Type 2 Diabetes.

Matsuba R, Sakai K, Imamura M, Tanaka Y, Iwata M, Hirose H, Kaku K, Maegawa H, Watada H, Tobe K, Kashiwagi A, Kawamori R, Maeda S.

PLoS One. 2015 May 7;10(5):e0126363. doi: 10.1371/journal.pone.0126363. eCollection 2015.

38.

Evaluation of the fatty acid composition of the seeds of Mangifera indica L. and their application.

Wu S, Tokuda M, Kashiwagi A, Henmi A, Okada Y, Tachibana S, Nomura M.

J Oleo Sci. 2015;64(5):479-84. doi: 10.5650/jos.ess14238.

39.

Homeolog-specific targeted mutagenesis in Xenopus laevis using TALENs.

Nakade S, Sakuma T, Sakane Y, Hara Y, Kurabayashi A, Kashiwagi K, Kashiwagi A, Yamamoto T, Obara M.

In Vitro Cell Dev Biol Anim. 2015 Oct;51(9):879-84. doi: 10.1007/s11626-015-9912-0. Epub 2015 Apr 29.

PMID:
25920501
40.

Characterization of a single mutation in TraQ in a strain of Escherichia coli partially resistant to Qβ infection.

Kashiwagi A, Kitamura H, Sano Tsushima F.

Front Microbiol. 2015 Feb 20;6:124. doi: 10.3389/fmicb.2015.00124. eCollection 2015.

41.

Anesthesia with Disuse Leads to Autophagy Up-regulation in the Skeletal Muscle.

Kashiwagi A, Hosokawa S, Maeyama Y, Ueki R, Kaneki M, Martyn JA, Yasuhara S.

Anesthesiology. 2015 May;122(5):1075-83. doi: 10.1097/ALN.0000000000000561.

42.

Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002-2011 in Japan (JDDM32).

Oishi M, Yamazaki K, Okuguchi F, Sugimoto H, Kanatsuka A, Kashiwagi A; Japan Diabetes Clinical Data Management Study Group.

J Diabetes Investig. 2014 Sep;5(5):581-7. doi: 10.1111/jdi.12183. Epub 2013 Dec 1.

43.

Evaluation of insulin regimens as an effective option for glycemic control in patients with type 2 diabetes: A propensity score-matched cohort study across Japan (JDDM31).

Kanatsuka A, Sato Y, Kawai K, Hirao K, Kobayashi M, Kashiwagi A; Japan Diabetes Clinical Data Management Study Group.

J Diabetes Investig. 2014 Sep;5(5):539-47. doi: 10.1111/jdi.12194. Epub 2014 Feb 26.

44.

Oral glucose-stimulated serum C-peptide predicts successful switching from insulin therapy to liraglutide monotherapy in Japanese patients with type 2 diabetes and renal impairment.

Araki H, Tanaka Y, Yoshida S, Morita Y, Kume S, Isshiki K, Araki S, Uzu T, Kashiwagi A, Maegawa H.

J Diabetes Investig. 2014 Jul;5(4):435-41. doi: 10.1111/jdi.12169. Epub 2013 Nov 28.

45.
47.

Comparison of HOMA-IR, HOMA-β% and disposition index between US white men and Japanese men in Japan: the ERA JUMP study.

Ahuja V, Kadowaki T, Evans RW, Kadota A, Okamura T, El Khoudary SR, Fujiyoshi A, Barinas-Mitchell EJ, Hisamatsu T, Vishnu A, Miura K, Maegawa H, El-Saed A, Kashiwagi A, Kuller LH, Ueshima H, Sekikawa A; ERA JUMP Study Group.

Diabetologia. 2015 Feb;58(2):265-71. doi: 10.1007/s00125-014-3414-6. Epub 2014 Oct 15.

48.
49.

Pharmacokinetic and pharmacodynamic study of ipragliflozin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study.

Kadokura T, Akiyama N, Kashiwagi A, Utsuno A, Kazuta K, Yoshida S, Nagase I, Smulders R, Kageyama S.

Diabetes Res Clin Pract. 2014 Oct;106(1):50-6. doi: 10.1016/j.diabres.2014.07.020. Epub 2014 Jul 26.

PMID:
25149596
50.

Contribution of silent mutations to thermal adaptation of RNA bacteriophage Qβ.

Kashiwagi A, Sugawara R, Sano Tsushima F, Kumagai T, Yomo T.

J Virol. 2014 Oct;88(19):11459-68. doi: 10.1128/JVI.01127-14. Epub 2014 Jul 23.

Supplemental Content

Loading ...
Support Center